nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—HTR7—epilepsy syndrome	0.125	0.415	CbGaD
Eletriptan—CYP2C19—epilepsy syndrome	0.0777	0.258	CbGaD
Eletriptan—CYP2D6—epilepsy syndrome	0.0576	0.191	CbGaD
Eletriptan—ABCB1—epilepsy syndrome	0.0412	0.136	CbGaD
Eletriptan—CYP2A6—Amobarbital—epilepsy syndrome	0.0215	0.0559	CbGbCtD
Eletriptan—CYP2A6—Propofol—epilepsy syndrome	0.0161	0.0417	CbGbCtD
Eletriptan—CYP2A6—Phenobarbital—epilepsy syndrome	0.0154	0.0398	CbGbCtD
Eletriptan—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0127	0.0328	CbGbCtD
Eletriptan—PTGS1—Diazepam—epilepsy syndrome	0.0124	0.0323	CbGbCtD
Eletriptan—CYP2C19—Felbamate—epilepsy syndrome	0.0118	0.0305	CbGbCtD
Eletriptan—CYP2C19—Trimethadione—epilepsy syndrome	0.0118	0.0305	CbGbCtD
Eletriptan—CYP2A6—Valproic Acid—epilepsy syndrome	0.0115	0.0298	CbGbCtD
Eletriptan—ABCB1—Levetiracetam—epilepsy syndrome	0.0112	0.029	CbGbCtD
Eletriptan—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0111	0.0287	CbGbCtD
Eletriptan—PTGS1—Valproic Acid—epilepsy syndrome	0.0098	0.0254	CbGbCtD
Eletriptan—CYP2C9—Trimethadione—epilepsy syndrome	0.00978	0.0254	CbGbCtD
Eletriptan—CYP2C19—Clobazam—epilepsy syndrome	0.00959	0.0249	CbGbCtD
Eletriptan—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00919	0.0238	CbGbCtD
Eletriptan—CYP2C19—Carbamazepine—epilepsy syndrome	0.00795	0.0206	CbGbCtD
Eletriptan—ABCB1—Clobazam—epilepsy syndrome	0.00774	0.0201	CbGbCtD
Eletriptan—ABCB1—Lamotrigine—epilepsy syndrome	0.00745	0.0193	CbGbCtD
Eletriptan—CYP2C19—Primidone—epilepsy syndrome	0.00742	0.0192	CbGbCtD
Eletriptan—CYP2C19—Phenytoin—epilepsy syndrome	0.00713	0.0185	CbGbCtD
Eletriptan—CYP2C19—Propofol—epilepsy syndrome	0.00665	0.0172	CbGbCtD
Eletriptan—CYP2C9—Carbamazepine—epilepsy syndrome	0.00661	0.0171	CbGbCtD
Eletriptan—HTR1D—meninx—epilepsy syndrome	0.00658	0.132	CbGeAlD
Eletriptan—ABCB1—Carbamazepine—epilepsy syndrome	0.00641	0.0166	CbGbCtD
Eletriptan—CYP2C19—Phenobarbital—epilepsy syndrome	0.00635	0.0165	CbGbCtD
Eletriptan—CYP2C9—Primidone—epilepsy syndrome	0.00617	0.016	CbGbCtD
Eletriptan—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00612	0.0159	CbGbCtD
Eletriptan—CYP2C19—Diazepam—epilepsy syndrome	0.00602	0.0156	CbGbCtD
Eletriptan—CYP2C9—Phenytoin—epilepsy syndrome	0.00592	0.0154	CbGbCtD
Eletriptan—CYP2C19—Zonisamide—epilepsy syndrome	0.00588	0.0152	CbGbCtD
Eletriptan—ABCB1—Phenytoin—epilepsy syndrome	0.00575	0.0149	CbGbCtD
Eletriptan—CYP3A4—Trimethadione—epilepsy syndrome	0.00569	0.0147	CbGbCtD
Eletriptan—CYP3A4—Felbamate—epilepsy syndrome	0.00569	0.0147	CbGbCtD
Eletriptan—CYP2C9—Propofol—epilepsy syndrome	0.00553	0.0143	CbGbCtD
Eletriptan—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00535	0.0139	CbGbCtD
Eletriptan—CYP2C9—Phenobarbital—epilepsy syndrome	0.00528	0.0137	CbGbCtD
Eletriptan—ABCB1—Phenobarbital—epilepsy syndrome	0.00512	0.0133	CbGbCtD
Eletriptan—ABCB1—Midazolam—epilepsy syndrome	0.00505	0.0131	CbGbCtD
Eletriptan—CYP2D6—Propofol—epilepsy syndrome	0.00505	0.0131	CbGbCtD
Eletriptan—CYP2C9—Diazepam—epilepsy syndrome	0.00501	0.013	CbGbCtD
Eletriptan—ABCB1—Diazepam—epilepsy syndrome	0.00486	0.0126	CbGbCtD
Eletriptan—CYP3A4—Clonazepam—epilepsy syndrome	0.00483	0.0125	CbGbCtD
Eletriptan—CYP2C19—Valproic Acid—epilepsy syndrome	0.00475	0.0123	CbGbCtD
Eletriptan—CYP3A4—Clobazam—epilepsy syndrome	0.00464	0.012	CbGbCtD
Eletriptan—CYP2C19—Topiramate—epilepsy syndrome	0.00428	0.0111	CbGbCtD
Eletriptan—CYP2C9—Valproic Acid—epilepsy syndrome	0.00395	0.0102	CbGbCtD
Eletriptan—CYP3A4—Rufinamide—epilepsy syndrome	0.00394	0.0102	CbGbCtD
Eletriptan—CYP3A4—Carbamazepine—epilepsy syndrome	0.00384	0.00996	CbGbCtD
Eletriptan—CYP3A4—Primidone—epilepsy syndrome	0.00359	0.0093	CbGbCtD
Eletriptan—CYP3A4—Phenytoin—epilepsy syndrome	0.00344	0.00894	CbGbCtD
Eletriptan—CYP3A4—Propofol—epilepsy syndrome	0.00321	0.00833	CbGbCtD
Eletriptan—CYP3A4—Acetazolamide—epilepsy syndrome	0.00307	0.00796	CbGbCtD
Eletriptan—CYP3A4—Phenobarbital—epilepsy syndrome	0.00307	0.00796	CbGbCtD
Eletriptan—CYP3A4—Midazolam—epilepsy syndrome	0.00303	0.00785	CbGbCtD
Eletriptan—CYP3A4—Diazepam—epilepsy syndrome	0.00291	0.00755	CbGbCtD
Eletriptan—CYP3A4—Zonisamide—epilepsy syndrome	0.00284	0.00737	CbGbCtD
Eletriptan—HTR7—locus ceruleus—epilepsy syndrome	0.00253	0.0509	CbGeAlD
Eletriptan—HTR1F—ganglion—epilepsy syndrome	0.00237	0.0476	CbGeAlD
Eletriptan—CYP3A4—Valproic Acid—epilepsy syndrome	0.00229	0.00595	CbGbCtD
Eletriptan—CYP3A4—Topiramate—epilepsy syndrome	0.00207	0.00537	CbGbCtD
Eletriptan—HTR7—vagus nerve—epilepsy syndrome	0.00194	0.039	CbGeAlD
Eletriptan—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00156	0.0313	CbGeAlD
Eletriptan—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00151	0.0303	CbGeAlD
Eletriptan—HTR7—pons—epilepsy syndrome	0.00146	0.0293	CbGeAlD
Eletriptan—HTR7—autonomic nervous system—epilepsy syndrome	0.00135	0.0271	CbGeAlD
Eletriptan—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00126	0.0253	CbGeAlD
Eletriptan—HTR7—telencephalic ventricle—epilepsy syndrome	0.0012	0.0241	CbGeAlD
Eletriptan—HTR1F—forebrain—epilepsy syndrome	0.000993	0.02	CbGeAlD
Eletriptan—HTR1B—ganglion—epilepsy syndrome	0.00097	0.0195	CbGeAlD
Eletriptan—HTR1D—ganglion—epilepsy syndrome	0.000939	0.0189	CbGeAlD
Eletriptan—HTR1F—telencephalon—epilepsy syndrome	0.000913	0.0183	CbGeAlD
Eletriptan—HTR1E—brainstem—epilepsy syndrome	0.000891	0.0179	CbGeAlD
Eletriptan—HTR1E—forebrain—epilepsy syndrome	0.00086	0.0173	CbGeAlD
Eletriptan—HTR1E—telencephalon—epilepsy syndrome	0.000791	0.0159	CbGeAlD
Eletriptan—HTR1A—ganglion—epilepsy syndrome	0.000783	0.0157	CbGeAlD
Eletriptan—HTR7—ganglion—epilepsy syndrome	0.000748	0.015	CbGeAlD
Eletriptan—HTR1A—hindbrain—epilepsy syndrome	0.000594	0.0119	CbGeAlD
Eletriptan—HTR1F—head—epilepsy syndrome	0.000569	0.0114	CbGeAlD
Eletriptan—HTR7—hindbrain—epilepsy syndrome	0.000567	0.0114	CbGeAlD
Eletriptan—HTR1F—nervous system—epilepsy syndrome	0.000539	0.0108	CbGeAlD
Eletriptan—Sumatriptan—SLCO1A2—epilepsy syndrome	0.000531	0.226	CrCbGaD
Eletriptan—HTR1F—central nervous system—epilepsy syndrome	0.000519	0.0104	CbGeAlD
Eletriptan—PTGS1—ganglion—epilepsy syndrome	0.000517	0.0104	CbGeAlD
Eletriptan—HTR1E—head—epilepsy syndrome	0.000493	0.0099	CbGeAlD
Eletriptan—HTR1E—nervous system—epilepsy syndrome	0.000467	0.00938	CbGeAlD
Eletriptan—HTR1E—central nervous system—epilepsy syndrome	0.00045	0.00903	CbGeAlD
Eletriptan—HTR1B—brainstem—epilepsy syndrome	0.000422	0.00847	CbGeAlD
Eletriptan—HTR1F—brain—epilepsy syndrome	0.000412	0.00828	CbGeAlD
Eletriptan—HTR1D—brainstem—epilepsy syndrome	0.000408	0.0082	CbGeAlD
Eletriptan—HTR1B—forebrain—epilepsy syndrome	0.000407	0.00818	CbGeAlD
Eletriptan—HTR1D—forebrain—epilepsy syndrome	0.000394	0.00792	CbGeAlD
Eletriptan—HTR1B—telencephalon—epilepsy syndrome	0.000374	0.00752	CbGeAlD
Eletriptan—HTR2B—forebrain—epilepsy syndrome	0.000366	0.00736	CbGeAlD
Eletriptan—HTR1D—telencephalon—epilepsy syndrome	0.000362	0.00728	CbGeAlD
Eletriptan—HTR1E—brain—epilepsy syndrome	0.000357	0.00717	CbGeAlD
Eletriptan—HTR1A—brainstem—epilepsy syndrome	0.00034	0.00684	CbGeAlD
Eletriptan—HTR2B—telencephalon—epilepsy syndrome	0.000337	0.00677	CbGeAlD
Eletriptan—HTR1A—forebrain—epilepsy syndrome	0.000328	0.0066	CbGeAlD
Eletriptan—HTR7—brainstem—epilepsy syndrome	0.000325	0.00653	CbGeAlD
Eletriptan—CYP2D6—hindbrain—epilepsy syndrome	0.000322	0.00648	CbGeAlD
Eletriptan—HTR7—forebrain—epilepsy syndrome	0.000314	0.00631	CbGeAlD
Eletriptan—HTR1A—telencephalon—epilepsy syndrome	0.000302	0.00607	CbGeAlD
Eletriptan—HTR7—telencephalon—epilepsy syndrome	0.000289	0.0058	CbGeAlD
Eletriptan—HTR1B—midbrain—epilepsy syndrome	0.000269	0.0054	CbGeAlD
Eletriptan—HTR1B—spinal cord—epilepsy syndrome	0.000262	0.00527	CbGeAlD
Eletriptan—HTR1D—midbrain—epilepsy syndrome	0.00026	0.00523	CbGeAlD
Eletriptan—CYP2A6—cerebellum—epilepsy syndrome	0.000243	0.00489	CbGeAlD
Eletriptan—HTR1B—head—epilepsy syndrome	0.000233	0.00468	CbGeAlD
Eletriptan—HTR7—medulla oblongata—epilepsy syndrome	0.000227	0.00456	CbGeAlD
Eletriptan—HTR1D—head—epilepsy syndrome	0.000226	0.00453	CbGeAlD
Eletriptan—Sumatriptan—ABCG2—epilepsy syndrome	0.000225	0.0955	CrCbGaD
Eletriptan—HTR1B—nervous system—epilepsy syndrome	0.000221	0.00444	CbGeAlD
Eletriptan—PTGS1—forebrain—epilepsy syndrome	0.000217	0.00436	CbGeAlD
Eletriptan—HTR1A—midbrain—epilepsy syndrome	0.000217	0.00436	CbGeAlD
Eletriptan—HTR1D—nervous system—epilepsy syndrome	0.000214	0.0043	CbGeAlD
Eletriptan—HTR1B—central nervous system—epilepsy syndrome	0.000213	0.00427	CbGeAlD
Eletriptan—HTR1A—spinal cord—epilepsy syndrome	0.000212	0.00425	CbGeAlD
Eletriptan—Encainide—CYP2D6—epilepsy syndrome	0.000211	0.0897	CrCbGaD
Eletriptan—HTR2B—head—epilepsy syndrome	0.00021	0.00422	CbGeAlD
Eletriptan—HTR7—midbrain—epilepsy syndrome	0.000207	0.00416	CbGeAlD
Eletriptan—HTR1D—central nervous system—epilepsy syndrome	0.000206	0.00414	CbGeAlD
Eletriptan—HTR7—spinal cord—epilepsy syndrome	0.000202	0.00406	CbGeAlD
Eletriptan—PTGS1—telencephalon—epilepsy syndrome	0.000199	0.00401	CbGeAlD
Eletriptan—HTR2B—nervous system—epilepsy syndrome	0.000199	0.004	CbGeAlD
Eletriptan—CYP2A6—brain—epilepsy syndrome	0.000198	0.00397	CbGeAlD
Eletriptan—HTR2B—central nervous system—epilepsy syndrome	0.000192	0.00385	CbGeAlD
Eletriptan—HTR1A—head—epilepsy syndrome	0.000188	0.00378	CbGeAlD
Eletriptan—CYP2D6—brainstem—epilepsy syndrome	0.000185	0.00371	CbGeAlD
Eletriptan—Almotriptan—CYP2C19—epilepsy syndrome	0.000183	0.078	CrCbGaD
Eletriptan—HTR7—head—epilepsy syndrome	0.00018	0.00361	CbGeAlD
Eletriptan—CYP2D6—forebrain—epilepsy syndrome	0.000178	0.00358	CbGeAlD
Eletriptan—HTR1A—nervous system—epilepsy syndrome	0.000178	0.00358	CbGeAlD
Eletriptan—HTR1A—central nervous system—epilepsy syndrome	0.000172	0.00345	CbGeAlD
Eletriptan—HTR7—nervous system—epilepsy syndrome	0.00017	0.00342	CbGeAlD
Eletriptan—HTR1B—brain—epilepsy syndrome	0.000169	0.00339	CbGeAlD
Eletriptan—HTR1A—cerebellum—epilepsy syndrome	0.000168	0.00337	CbGeAlD
Eletriptan—HTR7—central nervous system—epilepsy syndrome	0.000164	0.0033	CbGeAlD
Eletriptan—CYP2D6—telencephalon—epilepsy syndrome	0.000164	0.00329	CbGeAlD
Eletriptan—HTR1D—brain—epilepsy syndrome	0.000163	0.00328	CbGeAlD
Eletriptan—HTR7—cerebellum—epilepsy syndrome	0.00016	0.00322	CbGeAlD
Eletriptan—Clemastine—CYP2D6—epilepsy syndrome	0.000157	0.0667	CrCbGaD
Eletriptan—Mesoridazine—CHRM2—epilepsy syndrome	0.000154	0.0655	CrCbGaD
Eletriptan—HTR2B—brain—epilepsy syndrome	0.000152	0.00306	CbGeAlD
Eletriptan—PTGS1—spinal cord—epilepsy syndrome	0.00014	0.00281	CbGeAlD
Eletriptan—HTR1A—brain—epilepsy syndrome	0.000136	0.00274	CbGeAlD
Eletriptan—Almotriptan—CYP2D6—epilepsy syndrome	0.000136	0.0578	CrCbGaD
Eletriptan—HTR7—brain—epilepsy syndrome	0.00013	0.00262	CbGeAlD
Eletriptan—ABCB1—forebrain—epilepsy syndrome	0.000128	0.00258	CbGeAlD
Eletriptan—PTGS1—head—epilepsy syndrome	0.000124	0.0025	CbGeAlD
Eletriptan—ABCB1—telencephalon—epilepsy syndrome	0.000118	0.00237	CbGeAlD
Eletriptan—PTGS1—nervous system—epilepsy syndrome	0.000118	0.00237	CbGeAlD
Eletriptan—Thioridazine—CHRM2—epilepsy syndrome	0.000116	0.0494	CrCbGaD
Eletriptan—Thioridazine—HTR7—epilepsy syndrome	0.000116	0.0492	CrCbGaD
Eletriptan—PTGS1—central nervous system—epilepsy syndrome	0.000113	0.00228	CbGeAlD
Eletriptan—CYP2D6—head—epilepsy syndrome	0.000102	0.00205	CbGeAlD
Eletriptan—Thioridazine—ADRA2A—epilepsy syndrome	9.92e-05	0.0422	CrCbGaD
Eletriptan—CYP3A4—nervous system—epilepsy syndrome	9.84e-05	0.00198	CbGeAlD
Eletriptan—CYP2D6—nervous system—epilepsy syndrome	9.68e-05	0.00194	CbGeAlD
Eletriptan—CYP3A4—central nervous system—epilepsy syndrome	9.47e-05	0.0019	CbGeAlD
Eletriptan—Sumatriptan—ABCB1—epilepsy syndrome	9.34e-05	0.0397	CrCbGaD
Eletriptan—CYP2D6—central nervous system—epilepsy syndrome	9.32e-05	0.00187	CbGeAlD
Eletriptan—ABCB1—medulla oblongata—epilepsy syndrome	9.27e-05	0.00186	CbGeAlD
Eletriptan—CYP2D6—cerebellum—epilepsy syndrome	9.11e-05	0.00183	CbGeAlD
Eletriptan—PTGS1—brain—epilepsy syndrome	9e-05	0.00181	CbGeAlD
Eletriptan—ABCB1—midbrain—epilepsy syndrome	8.47e-05	0.0017	CbGeAlD
Eletriptan—ABCB1—spinal cord—epilepsy syndrome	8.26e-05	0.00166	CbGeAlD
Eletriptan—Mesoridazine—HTR2A—epilepsy syndrome	7.71e-05	0.0328	CrCbGaD
Eletriptan—CYP2D6—brain—epilepsy syndrome	7.4e-05	0.00149	CbGeAlD
Eletriptan—ABCB1—head—epilepsy syndrome	7.34e-05	0.00148	CbGeAlD
Eletriptan—Thioridazine—CYP2C19—epilepsy syndrome	7.17e-05	0.0305	CrCbGaD
Eletriptan—Mesoridazine—CYP2D6—epilepsy syndrome	7.05e-05	0.03	CrCbGaD
Eletriptan—ABCB1—nervous system—epilepsy syndrome	6.96e-05	0.0014	CbGeAlD
Eletriptan—ABCB1—central nervous system—epilepsy syndrome	6.7e-05	0.00135	CbGeAlD
Eletriptan—ABCB1—cerebellum—epilepsy syndrome	6.55e-05	0.00132	CbGeAlD
Eletriptan—Thioridazine—HTR2A—epilepsy syndrome	5.81e-05	0.0247	CrCbGaD
Eletriptan—ABCB1—brain—epilepsy syndrome	5.32e-05	0.00107	CbGeAlD
Eletriptan—Thioridazine—CYP2D6—epilepsy syndrome	5.32e-05	0.0226	CrCbGaD
Eletriptan—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.59e-05	0.000145	CcSEcCtD
Eletriptan—Headache—Vigabatrin—epilepsy syndrome	2.59e-05	0.000145	CcSEcCtD
Eletriptan—Hypertension—Pregabalin—epilepsy syndrome	2.59e-05	0.000145	CcSEcCtD
Eletriptan—Vomiting—Diazepam—epilepsy syndrome	2.59e-05	0.000145	CcSEcCtD
Eletriptan—Anorexia—Valproic Acid—epilepsy syndrome	2.58e-05	0.000144	CcSEcCtD
Eletriptan—Tremor—Gabapentin—epilepsy syndrome	2.57e-05	0.000144	CcSEcCtD
Eletriptan—Rash—Diazepam—epilepsy syndrome	2.56e-05	0.000144	CcSEcCtD
Eletriptan—Dermatitis—Diazepam—epilepsy syndrome	2.56e-05	0.000144	CcSEcCtD
Eletriptan—Visual impairment—Topiramate—epilepsy syndrome	2.56e-05	0.000143	CcSEcCtD
Eletriptan—Arthralgia—Pregabalin—epilepsy syndrome	2.55e-05	0.000143	CcSEcCtD
Eletriptan—Myalgia—Pregabalin—epilepsy syndrome	2.55e-05	0.000143	CcSEcCtD
Eletriptan—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.55e-05	0.000143	CcSEcCtD
Eletriptan—Dizziness—Zonisamide—epilepsy syndrome	2.55e-05	0.000143	CcSEcCtD
Eletriptan—Headache—Diazepam—epilepsy syndrome	2.55e-05	0.000143	CcSEcCtD
Eletriptan—Anxiety—Pregabalin—epilepsy syndrome	2.54e-05	0.000142	CcSEcCtD
Eletriptan—Diarrhoea—Clonazepam—epilepsy syndrome	2.54e-05	0.000142	CcSEcCtD
Eletriptan—Anaemia—Gabapentin—epilepsy syndrome	2.54e-05	0.000142	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.53e-05	0.000142	CcSEcCtD
Eletriptan—Hypotension—Valproic Acid—epilepsy syndrome	2.53e-05	0.000142	CcSEcCtD
Eletriptan—Asthenia—Carbamazepine—epilepsy syndrome	2.53e-05	0.000142	CcSEcCtD
Eletriptan—Agitation—Gabapentin—epilepsy syndrome	2.52e-05	0.000141	CcSEcCtD
Eletriptan—Diarrhoea—Phenytoin—epilepsy syndrome	2.52e-05	0.000141	CcSEcCtD
Eletriptan—Discomfort—Pregabalin—epilepsy syndrome	2.52e-05	0.000141	CcSEcCtD
Eletriptan—Nausea—Fosphenytoin—epilepsy syndrome	2.52e-05	0.000141	CcSEcCtD
Eletriptan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.51e-05	0.000141	CcSEcCtD
Eletriptan—Angioedema—Gabapentin—epilepsy syndrome	2.51e-05	0.000141	CcSEcCtD
Eletriptan—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.51e-05	0.000141	CcSEcCtD
Eletriptan—Vomiting—Felbamate—epilepsy syndrome	2.5e-05	0.00014	CcSEcCtD
Eletriptan—Dry mouth—Pregabalin—epilepsy syndrome	2.49e-05	0.00014	CcSEcCtD
Eletriptan—Pruritus—Carbamazepine—epilepsy syndrome	2.49e-05	0.00014	CcSEcCtD
Eletriptan—Rash—Felbamate—epilepsy syndrome	2.48e-05	0.000139	CcSEcCtD
Eletriptan—Dermatitis—Felbamate—epilepsy syndrome	2.48e-05	0.000139	CcSEcCtD
Eletriptan—Malaise—Gabapentin—epilepsy syndrome	2.48e-05	0.000139	CcSEcCtD
Eletriptan—Tinnitus—Topiramate—epilepsy syndrome	2.47e-05	0.000139	CcSEcCtD
Eletriptan—Vertigo—Gabapentin—epilepsy syndrome	2.47e-05	0.000138	CcSEcCtD
Eletriptan—Headache—Felbamate—epilepsy syndrome	2.47e-05	0.000138	CcSEcCtD
Eletriptan—Confusional state—Pregabalin—epilepsy syndrome	2.46e-05	0.000138	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.46e-05	0.000138	CcSEcCtD
Eletriptan—Flushing—Topiramate—epilepsy syndrome	2.46e-05	0.000138	CcSEcCtD
Eletriptan—Syncope—Gabapentin—epilepsy syndrome	2.46e-05	0.000138	CcSEcCtD
Eletriptan—Leukopenia—Gabapentin—epilepsy syndrome	2.46e-05	0.000138	CcSEcCtD
Eletriptan—Dizziness—Clonazepam—epilepsy syndrome	2.46e-05	0.000138	CcSEcCtD
Eletriptan—Nausea—Vigabatrin—epilepsy syndrome	2.45e-05	0.000138	CcSEcCtD
Eletriptan—Vomiting—Zonisamide—epilepsy syndrome	2.45e-05	0.000137	CcSEcCtD
Eletriptan—Insomnia—Valproic Acid—epilepsy syndrome	2.45e-05	0.000137	CcSEcCtD
Eletriptan—Oedema—Pregabalin—epilepsy syndrome	2.44e-05	0.000137	CcSEcCtD
Eletriptan—Asthenia—Lamotrigine—epilepsy syndrome	2.44e-05	0.000137	CcSEcCtD
Eletriptan—Dizziness—Phenytoin—epilepsy syndrome	2.44e-05	0.000137	CcSEcCtD
Eletriptan—Rash—Zonisamide—epilepsy syndrome	2.43e-05	0.000136	CcSEcCtD
Eletriptan—Paraesthesia—Valproic Acid—epilepsy syndrome	2.43e-05	0.000136	CcSEcCtD
Eletriptan—Palpitations—Gabapentin—epilepsy syndrome	2.43e-05	0.000136	CcSEcCtD
Eletriptan—Dermatitis—Zonisamide—epilepsy syndrome	2.43e-05	0.000136	CcSEcCtD
Eletriptan—Dizziness—Oxcarbazepine—epilepsy syndrome	2.43e-05	0.000136	CcSEcCtD
Eletriptan—Nausea—Diazepam—epilepsy syndrome	2.42e-05	0.000135	CcSEcCtD
Eletriptan—Loss of consciousness—Gabapentin—epilepsy syndrome	2.41e-05	0.000135	CcSEcCtD
Eletriptan—Headache—Zonisamide—epilepsy syndrome	2.41e-05	0.000135	CcSEcCtD
Eletriptan—Dyspnoea—Valproic Acid—epilepsy syndrome	2.41e-05	0.000135	CcSEcCtD
Eletriptan—Diarrhoea—Carbamazepine—epilepsy syndrome	2.41e-05	0.000135	CcSEcCtD
Eletriptan—Pruritus—Lamotrigine—epilepsy syndrome	2.41e-05	0.000135	CcSEcCtD
Eletriptan—Shock—Pregabalin—epilepsy syndrome	2.4e-05	0.000135	CcSEcCtD
Eletriptan—Somnolence—Valproic Acid—epilepsy syndrome	2.4e-05	0.000135	CcSEcCtD
Eletriptan—Immune system disorder—Topiramate—epilepsy syndrome	2.4e-05	0.000134	CcSEcCtD
Eletriptan—Nervous system disorder—Pregabalin—epilepsy syndrome	2.4e-05	0.000134	CcSEcCtD
Eletriptan—Cough—Gabapentin—epilepsy syndrome	2.4e-05	0.000134	CcSEcCtD
Eletriptan—Tachycardia—Pregabalin—epilepsy syndrome	2.39e-05	0.000134	CcSEcCtD
Eletriptan—Chills—Topiramate—epilepsy syndrome	2.38e-05	0.000134	CcSEcCtD
Eletriptan—Dyspepsia—Valproic Acid—epilepsy syndrome	2.38e-05	0.000133	CcSEcCtD
Eletriptan—Convulsion—Gabapentin—epilepsy syndrome	2.38e-05	0.000133	CcSEcCtD
Eletriptan—Skin disorder—Pregabalin—epilepsy syndrome	2.37e-05	0.000133	CcSEcCtD
Eletriptan—Hypertension—Gabapentin—epilepsy syndrome	2.37e-05	0.000133	CcSEcCtD
Eletriptan—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.36e-05	0.000132	CcSEcCtD
Eletriptan—Vomiting—Clonazepam—epilepsy syndrome	2.36e-05	0.000132	CcSEcCtD
Eletriptan—Decreased appetite—Valproic Acid—epilepsy syndrome	2.35e-05	0.000132	CcSEcCtD
Eletriptan—Alopecia—Topiramate—epilepsy syndrome	2.35e-05	0.000131	CcSEcCtD
Eletriptan—Vomiting—Phenytoin—epilepsy syndrome	2.34e-05	0.000131	CcSEcCtD
Eletriptan—Rash—Clonazepam—epilepsy syndrome	2.34e-05	0.000131	CcSEcCtD
Eletriptan—Dermatitis—Clonazepam—epilepsy syndrome	2.34e-05	0.000131	CcSEcCtD
Eletriptan—Arthralgia—Gabapentin—epilepsy syndrome	2.34e-05	0.000131	CcSEcCtD
Eletriptan—Myalgia—Gabapentin—epilepsy syndrome	2.34e-05	0.000131	CcSEcCtD
Eletriptan—Nausea—Felbamate—epilepsy syndrome	2.34e-05	0.000131	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.33e-05	0.000131	CcSEcCtD
Eletriptan—Vomiting—Oxcarbazepine—epilepsy syndrome	2.33e-05	0.000131	CcSEcCtD
Eletriptan—Fatigue—Valproic Acid—epilepsy syndrome	2.33e-05	0.000131	CcSEcCtD
Eletriptan—Anxiety—Gabapentin—epilepsy syndrome	2.33e-05	0.000131	CcSEcCtD
Eletriptan—Anorexia—Pregabalin—epilepsy syndrome	2.33e-05	0.000131	CcSEcCtD
Eletriptan—Dizziness—Carbamazepine—epilepsy syndrome	2.33e-05	0.000131	CcSEcCtD
Eletriptan—Diarrhoea—Lamotrigine—epilepsy syndrome	2.33e-05	0.000131	CcSEcCtD
Eletriptan—Headache—Clonazepam—epilepsy syndrome	2.33e-05	0.00013	CcSEcCtD
Eletriptan—Rash—Phenytoin—epilepsy syndrome	2.33e-05	0.00013	CcSEcCtD
Eletriptan—Dermatitis—Phenytoin—epilepsy syndrome	2.32e-05	0.00013	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.32e-05	0.00013	CcSEcCtD
Eletriptan—Rash—Oxcarbazepine—epilepsy syndrome	2.31e-05	0.00013	CcSEcCtD
Eletriptan—Pain—Valproic Acid—epilepsy syndrome	2.31e-05	0.00013	CcSEcCtD
Eletriptan—Constipation—Valproic Acid—epilepsy syndrome	2.31e-05	0.00013	CcSEcCtD
Eletriptan—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.31e-05	0.00013	CcSEcCtD
Eletriptan—Headache—Phenytoin—epilepsy syndrome	2.31e-05	0.00013	CcSEcCtD
Eletriptan—Discomfort—Gabapentin—epilepsy syndrome	2.31e-05	0.00013	CcSEcCtD
Eletriptan—Headache—Oxcarbazepine—epilepsy syndrome	2.3e-05	0.000129	CcSEcCtD
Eletriptan—Nausea—Zonisamide—epilepsy syndrome	2.29e-05	0.000128	CcSEcCtD
Eletriptan—Dry mouth—Gabapentin—epilepsy syndrome	2.29e-05	0.000128	CcSEcCtD
Eletriptan—Hypotension—Pregabalin—epilepsy syndrome	2.28e-05	0.000128	CcSEcCtD
Eletriptan—Flatulence—Topiramate—epilepsy syndrome	2.28e-05	0.000128	CcSEcCtD
Eletriptan—Tension—Topiramate—epilepsy syndrome	2.27e-05	0.000127	CcSEcCtD
Eletriptan—Dysgeusia—Topiramate—epilepsy syndrome	2.26e-05	0.000127	CcSEcCtD
Eletriptan—Confusional state—Gabapentin—epilepsy syndrome	2.26e-05	0.000127	CcSEcCtD
Eletriptan—Dizziness—Lamotrigine—epilepsy syndrome	2.25e-05	0.000126	CcSEcCtD
Eletriptan—Nervousness—Topiramate—epilepsy syndrome	2.24e-05	0.000126	CcSEcCtD
Eletriptan—Oedema—Gabapentin—epilepsy syndrome	2.24e-05	0.000126	CcSEcCtD
Eletriptan—Vomiting—Carbamazepine—epilepsy syndrome	2.24e-05	0.000125	CcSEcCtD
Eletriptan—Back pain—Topiramate—epilepsy syndrome	2.23e-05	0.000125	CcSEcCtD
Eletriptan—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.23e-05	0.000125	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.23e-05	0.000125	CcSEcCtD
Eletriptan—Muscle spasms—Topiramate—epilepsy syndrome	2.22e-05	0.000125	CcSEcCtD
Eletriptan—Rash—Carbamazepine—epilepsy syndrome	2.22e-05	0.000124	CcSEcCtD
Eletriptan—Dermatitis—Carbamazepine—epilepsy syndrome	2.22e-05	0.000124	CcSEcCtD
Eletriptan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.21e-05	0.000124	CcSEcCtD
Eletriptan—Insomnia—Pregabalin—epilepsy syndrome	2.21e-05	0.000124	CcSEcCtD
Eletriptan—Nausea—Clonazepam—epilepsy syndrome	2.21e-05	0.000124	CcSEcCtD
Eletriptan—Headache—Carbamazepine—epilepsy syndrome	2.21e-05	0.000124	CcSEcCtD
Eletriptan—Shock—Gabapentin—epilepsy syndrome	2.2e-05	0.000124	CcSEcCtD
Eletriptan—Nervous system disorder—Gabapentin—epilepsy syndrome	2.2e-05	0.000123	CcSEcCtD
Eletriptan—Paraesthesia—Pregabalin—epilepsy syndrome	2.19e-05	0.000123	CcSEcCtD
Eletriptan—Nausea—Phenytoin—epilepsy syndrome	2.19e-05	0.000123	CcSEcCtD
Eletriptan—Tachycardia—Gabapentin—epilepsy syndrome	2.19e-05	0.000123	CcSEcCtD
Eletriptan—Dyspnoea—Pregabalin—epilepsy syndrome	2.18e-05	0.000122	CcSEcCtD
Eletriptan—Nausea—Oxcarbazepine—epilepsy syndrome	2.18e-05	0.000122	CcSEcCtD
Eletriptan—Skin disorder—Gabapentin—epilepsy syndrome	2.18e-05	0.000122	CcSEcCtD
Eletriptan—Somnolence—Pregabalin—epilepsy syndrome	2.17e-05	0.000122	CcSEcCtD
Eletriptan—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.17e-05	0.000121	CcSEcCtD
Eletriptan—Tremor—Topiramate—epilepsy syndrome	2.16e-05	0.000121	CcSEcCtD
Eletriptan—Vomiting—Lamotrigine—epilepsy syndrome	2.16e-05	0.000121	CcSEcCtD
Eletriptan—Urticaria—Valproic Acid—epilepsy syndrome	2.15e-05	0.00012	CcSEcCtD
Eletriptan—Rash—Lamotrigine—epilepsy syndrome	2.15e-05	0.00012	CcSEcCtD
Eletriptan—Ill-defined disorder—Topiramate—epilepsy syndrome	2.14e-05	0.00012	CcSEcCtD
Eletriptan—Dermatitis—Lamotrigine—epilepsy syndrome	2.14e-05	0.00012	CcSEcCtD
Eletriptan—Body temperature increased—Valproic Acid—epilepsy syndrome	2.14e-05	0.00012	CcSEcCtD
Eletriptan—Abdominal pain—Valproic Acid—epilepsy syndrome	2.14e-05	0.00012	CcSEcCtD
Eletriptan—Anorexia—Gabapentin—epilepsy syndrome	2.14e-05	0.00012	CcSEcCtD
Eletriptan—Anaemia—Topiramate—epilepsy syndrome	2.14e-05	0.00012	CcSEcCtD
Eletriptan—Headache—Lamotrigine—epilepsy syndrome	2.13e-05	0.00012	CcSEcCtD
Eletriptan—Decreased appetite—Pregabalin—epilepsy syndrome	2.12e-05	0.000119	CcSEcCtD
Eletriptan—Agitation—Topiramate—epilepsy syndrome	2.12e-05	0.000119	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.11e-05	0.000118	CcSEcCtD
Eletriptan—Fatigue—Pregabalin—epilepsy syndrome	2.11e-05	0.000118	CcSEcCtD
Eletriptan—Hypotension—Gabapentin—epilepsy syndrome	2.09e-05	0.000117	CcSEcCtD
Eletriptan—Nausea—Carbamazepine—epilepsy syndrome	2.09e-05	0.000117	CcSEcCtD
Eletriptan—Constipation—Pregabalin—epilepsy syndrome	2.09e-05	0.000117	CcSEcCtD
Eletriptan—Pain—Pregabalin—epilepsy syndrome	2.09e-05	0.000117	CcSEcCtD
Eletriptan—Malaise—Topiramate—epilepsy syndrome	2.08e-05	0.000117	CcSEcCtD
Eletriptan—Vertigo—Topiramate—epilepsy syndrome	2.08e-05	0.000116	CcSEcCtD
Eletriptan—Syncope—Topiramate—epilepsy syndrome	2.07e-05	0.000116	CcSEcCtD
Eletriptan—Leukopenia—Topiramate—epilepsy syndrome	2.07e-05	0.000116	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.04e-05	0.000114	CcSEcCtD
Eletriptan—Palpitations—Topiramate—epilepsy syndrome	2.04e-05	0.000114	CcSEcCtD
Eletriptan—Loss of consciousness—Topiramate—epilepsy syndrome	2.03e-05	0.000114	CcSEcCtD
Eletriptan—Insomnia—Gabapentin—epilepsy syndrome	2.03e-05	0.000114	CcSEcCtD
Eletriptan—Nausea—Lamotrigine—epilepsy syndrome	2.02e-05	0.000113	CcSEcCtD
Eletriptan—Cough—Topiramate—epilepsy syndrome	2.02e-05	0.000113	CcSEcCtD
Eletriptan—Feeling abnormal—Pregabalin—epilepsy syndrome	2.01e-05	0.000113	CcSEcCtD
Eletriptan—Paraesthesia—Gabapentin—epilepsy syndrome	2.01e-05	0.000113	CcSEcCtD
Eletriptan—Convulsion—Topiramate—epilepsy syndrome	2e-05	0.000112	CcSEcCtD
Eletriptan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2e-05	0.000112	CcSEcCtD
Eletriptan—Dyspnoea—Gabapentin—epilepsy syndrome	2e-05	0.000112	CcSEcCtD
Eletriptan—Hypertension—Topiramate—epilepsy syndrome	1.99e-05	0.000112	CcSEcCtD
Eletriptan—Somnolence—Gabapentin—epilepsy syndrome	1.99e-05	0.000112	CcSEcCtD
Eletriptan—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.99e-05	0.000112	CcSEcCtD
Eletriptan—Dyspepsia—Gabapentin—epilepsy syndrome	1.97e-05	0.000111	CcSEcCtD
Eletriptan—Arthralgia—Topiramate—epilepsy syndrome	1.97e-05	0.00011	CcSEcCtD
Eletriptan—Myalgia—Topiramate—epilepsy syndrome	1.97e-05	0.00011	CcSEcCtD
Eletriptan—Anxiety—Topiramate—epilepsy syndrome	1.96e-05	0.00011	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.95e-05	0.00011	CcSEcCtD
Eletriptan—Decreased appetite—Gabapentin—epilepsy syndrome	1.95e-05	0.000109	CcSEcCtD
Eletriptan—Discomfort—Topiramate—epilepsy syndrome	1.94e-05	0.000109	CcSEcCtD
Eletriptan—Urticaria—Pregabalin—epilepsy syndrome	1.94e-05	0.000109	CcSEcCtD
Eletriptan—Asthenia—Valproic Acid—epilepsy syndrome	1.94e-05	0.000109	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.93e-05	0.000108	CcSEcCtD
Eletriptan—Fatigue—Gabapentin—epilepsy syndrome	1.93e-05	0.000108	CcSEcCtD
Eletriptan—Body temperature increased—Pregabalin—epilepsy syndrome	1.93e-05	0.000108	CcSEcCtD
Eletriptan—Abdominal pain—Pregabalin—epilepsy syndrome	1.93e-05	0.000108	CcSEcCtD
Eletriptan—Dry mouth—Topiramate—epilepsy syndrome	1.92e-05	0.000108	CcSEcCtD
Eletriptan—Constipation—Gabapentin—epilepsy syndrome	1.92e-05	0.000107	CcSEcCtD
Eletriptan—Pain—Gabapentin—epilepsy syndrome	1.92e-05	0.000107	CcSEcCtD
Eletriptan—Pruritus—Valproic Acid—epilepsy syndrome	1.91e-05	0.000107	CcSEcCtD
Eletriptan—Confusional state—Topiramate—epilepsy syndrome	1.9e-05	0.000107	CcSEcCtD
Eletriptan—Oedema—Topiramate—epilepsy syndrome	1.89e-05	0.000106	CcSEcCtD
Eletriptan—Shock—Topiramate—epilepsy syndrome	1.86e-05	0.000104	CcSEcCtD
Eletriptan—Diarrhoea—Valproic Acid—epilepsy syndrome	1.85e-05	0.000104	CcSEcCtD
Eletriptan—Nervous system disorder—Topiramate—epilepsy syndrome	1.85e-05	0.000104	CcSEcCtD
Eletriptan—Feeling abnormal—Gabapentin—epilepsy syndrome	1.85e-05	0.000104	CcSEcCtD
Eletriptan—Tachycardia—Topiramate—epilepsy syndrome	1.84e-05	0.000103	CcSEcCtD
Eletriptan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.83e-05	0.000103	CcSEcCtD
Eletriptan—Skin disorder—Topiramate—epilepsy syndrome	1.83e-05	0.000103	CcSEcCtD
Eletriptan—Hyperhidrosis—Topiramate—epilepsy syndrome	1.82e-05	0.000102	CcSEcCtD
Eletriptan—Hypersensitivity—Pregabalin—epilepsy syndrome	1.8e-05	0.000101	CcSEcCtD
Eletriptan—Anorexia—Topiramate—epilepsy syndrome	1.8e-05	0.000101	CcSEcCtD
Eletriptan—Dizziness—Valproic Acid—epilepsy syndrome	1.79e-05	0.0001	CcSEcCtD
Eletriptan—Urticaria—Gabapentin—epilepsy syndrome	1.78e-05	9.98e-05	CcSEcCtD
Eletriptan—Abdominal pain—Gabapentin—epilepsy syndrome	1.77e-05	9.93e-05	CcSEcCtD
Eletriptan—Body temperature increased—Gabapentin—epilepsy syndrome	1.77e-05	9.93e-05	CcSEcCtD
Eletriptan—Hypotension—Topiramate—epilepsy syndrome	1.76e-05	9.88e-05	CcSEcCtD
Eletriptan—Asthenia—Pregabalin—epilepsy syndrome	1.75e-05	9.83e-05	CcSEcCtD
Eletriptan—Pruritus—Pregabalin—epilepsy syndrome	1.73e-05	9.7e-05	CcSEcCtD
Eletriptan—Vomiting—Valproic Acid—epilepsy syndrome	1.72e-05	9.64e-05	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.72e-05	9.63e-05	CcSEcCtD
Eletriptan—Insomnia—Topiramate—epilepsy syndrome	1.71e-05	9.56e-05	CcSEcCtD
Eletriptan—Rash—Valproic Acid—epilepsy syndrome	1.7e-05	9.56e-05	CcSEcCtD
Eletriptan—Dermatitis—Valproic Acid—epilepsy syndrome	1.7e-05	9.55e-05	CcSEcCtD
Eletriptan—Headache—Valproic Acid—epilepsy syndrome	1.69e-05	9.5e-05	CcSEcCtD
Eletriptan—Paraesthesia—Topiramate—epilepsy syndrome	1.69e-05	9.49e-05	CcSEcCtD
Eletriptan—Dyspnoea—Topiramate—epilepsy syndrome	1.68e-05	9.43e-05	CcSEcCtD
Eletriptan—Somnolence—Topiramate—epilepsy syndrome	1.68e-05	9.4e-05	CcSEcCtD
Eletriptan—Diarrhoea—Pregabalin—epilepsy syndrome	1.67e-05	9.38e-05	CcSEcCtD
Eletriptan—Dyspepsia—Topiramate—epilepsy syndrome	1.66e-05	9.31e-05	CcSEcCtD
Eletriptan—Hypersensitivity—Gabapentin—epilepsy syndrome	1.65e-05	9.26e-05	CcSEcCtD
Eletriptan—Decreased appetite—Topiramate—epilepsy syndrome	1.64e-05	9.19e-05	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.63e-05	9.13e-05	CcSEcCtD
Eletriptan—Fatigue—Topiramate—epilepsy syndrome	1.63e-05	9.11e-05	CcSEcCtD
Eletriptan—Dizziness—Pregabalin—epilepsy syndrome	1.62e-05	9.06e-05	CcSEcCtD
Eletriptan—Pain—Topiramate—epilepsy syndrome	1.61e-05	9.04e-05	CcSEcCtD
Eletriptan—Constipation—Topiramate—epilepsy syndrome	1.61e-05	9.04e-05	CcSEcCtD
Eletriptan—Asthenia—Gabapentin—epilepsy syndrome	1.61e-05	9.02e-05	CcSEcCtD
Eletriptan—Nausea—Valproic Acid—epilepsy syndrome	1.61e-05	9e-05	CcSEcCtD
Eletriptan—Pruritus—Gabapentin—epilepsy syndrome	1.59e-05	8.89e-05	CcSEcCtD
Eletriptan—Vomiting—Pregabalin—epilepsy syndrome	1.55e-05	8.71e-05	CcSEcCtD
Eletriptan—Feeling abnormal—Topiramate—epilepsy syndrome	1.55e-05	8.71e-05	CcSEcCtD
Eletriptan—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.54e-05	8.65e-05	CcSEcCtD
Eletriptan—Rash—Pregabalin—epilepsy syndrome	1.54e-05	8.64e-05	CcSEcCtD
Eletriptan—Dermatitis—Pregabalin—epilepsy syndrome	1.54e-05	8.63e-05	CcSEcCtD
Eletriptan—Diarrhoea—Gabapentin—epilepsy syndrome	1.53e-05	8.6e-05	CcSEcCtD
Eletriptan—Headache—Pregabalin—epilepsy syndrome	1.53e-05	8.59e-05	CcSEcCtD
Eletriptan—Urticaria—Topiramate—epilepsy syndrome	1.5e-05	8.4e-05	CcSEcCtD
Eletriptan—Abdominal pain—Topiramate—epilepsy syndrome	1.49e-05	8.36e-05	CcSEcCtD
Eletriptan—Body temperature increased—Topiramate—epilepsy syndrome	1.49e-05	8.36e-05	CcSEcCtD
Eletriptan—Dizziness—Gabapentin—epilepsy syndrome	1.48e-05	8.31e-05	CcSEcCtD
Eletriptan—Nausea—Pregabalin—epilepsy syndrome	1.45e-05	8.14e-05	CcSEcCtD
Eletriptan—Vomiting—Gabapentin—epilepsy syndrome	1.42e-05	7.99e-05	CcSEcCtD
Eletriptan—Rash—Gabapentin—epilepsy syndrome	1.41e-05	7.92e-05	CcSEcCtD
Eletriptan—Dermatitis—Gabapentin—epilepsy syndrome	1.41e-05	7.92e-05	CcSEcCtD
Eletriptan—Headache—Gabapentin—epilepsy syndrome	1.4e-05	7.87e-05	CcSEcCtD
Eletriptan—Hypersensitivity—Topiramate—epilepsy syndrome	1.39e-05	7.79e-05	CcSEcCtD
Eletriptan—Asthenia—Topiramate—epilepsy syndrome	1.35e-05	7.59e-05	CcSEcCtD
Eletriptan—Pruritus—Topiramate—epilepsy syndrome	1.33e-05	7.48e-05	CcSEcCtD
Eletriptan—Nausea—Gabapentin—epilepsy syndrome	1.33e-05	7.46e-05	CcSEcCtD
Eletriptan—Diarrhoea—Topiramate—epilepsy syndrome	1.29e-05	7.23e-05	CcSEcCtD
Eletriptan—Dizziness—Topiramate—epilepsy syndrome	1.25e-05	6.99e-05	CcSEcCtD
Eletriptan—Vomiting—Topiramate—epilepsy syndrome	1.2e-05	6.72e-05	CcSEcCtD
Eletriptan—Rash—Topiramate—epilepsy syndrome	1.19e-05	6.67e-05	CcSEcCtD
Eletriptan—Dermatitis—Topiramate—epilepsy syndrome	1.19e-05	6.66e-05	CcSEcCtD
Eletriptan—Headache—Topiramate—epilepsy syndrome	1.18e-05	6.62e-05	CcSEcCtD
Eletriptan—Nausea—Topiramate—epilepsy syndrome	1.12e-05	6.28e-05	CcSEcCtD
Eletriptan—HTR1E—Signaling Pathways—MTOR—epilepsy syndrome	2.91e-06	3.54e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	2.91e-06	3.54e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.9e-06	3.53e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.9e-06	3.53e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.9e-06	3.53e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCR5—epilepsy syndrome	2.88e-06	3.51e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	2.88e-06	3.5e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—APOE—epilepsy syndrome	2.87e-06	3.5e-05	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—AKT1—epilepsy syndrome	2.86e-06	3.49e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GPX1—epilepsy syndrome	2.86e-06	3.48e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TSC2—epilepsy syndrome	2.85e-06	3.48e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—APOE—epilepsy syndrome	2.85e-06	3.47e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AGT—epilepsy syndrome	2.85e-06	3.47e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	2.85e-06	3.47e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	2.84e-06	3.46e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	2.84e-06	3.46e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CASP3—epilepsy syndrome	2.84e-06	3.45e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HTR2A—epilepsy syndrome	2.82e-06	3.44e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KDR—epilepsy syndrome	2.81e-06	3.42e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KDR—epilepsy syndrome	2.79e-06	3.4e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—APOE—epilepsy syndrome	2.79e-06	3.4e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.77e-06	3.38e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.77e-06	3.37e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.77e-06	3.37e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—JUN—epilepsy syndrome	2.76e-06	3.36e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2.75e-06	3.35e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	2.75e-06	3.35e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KDR—epilepsy syndrome	2.74e-06	3.33e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.73e-06	3.33e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PRKCB—epilepsy syndrome	2.71e-06	3.3e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.71e-06	3.3e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GPX1—epilepsy syndrome	2.71e-06	3.29e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.7e-06	3.29e-05	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—AKT1—epilepsy syndrome	2.7e-06	3.29e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6ST—epilepsy syndrome	2.7e-06	3.28e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PRKCB—epilepsy syndrome	2.69e-06	3.28e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.69e-06	3.27e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MMP9—epilepsy syndrome	2.68e-06	3.26e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TSC2—epilepsy syndrome	2.68e-06	3.26e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6ST—epilepsy syndrome	2.68e-06	3.26e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AGT—epilepsy syndrome	2.68e-06	3.26e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CASP3—epilepsy syndrome	2.68e-06	3.26e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.65e-06	3.23e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PRKCB—epilepsy syndrome	2.63e-06	3.21e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—APOE—epilepsy syndrome	2.62e-06	3.19e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6ST—epilepsy syndrome	2.62e-06	3.19e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.61e-06	3.18e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.6e-06	3.17e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	2.6e-06	3.17e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—AKT1—epilepsy syndrome	2.6e-06	3.17e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—JUN—epilepsy syndrome	2.6e-06	3.17e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.59e-06	3.16e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KDR—epilepsy syndrome	2.57e-06	3.13e-05	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.56e-06	3.12e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.55e-06	3.11e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.55e-06	3.1e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.53e-06	3.08e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MMP9—epilepsy syndrome	2.53e-06	3.08e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	2.53e-06	3.08e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.53e-06	3.08e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	2.52e-06	3.07e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	2.52e-06	3.06e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.51e-06	3.06e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AGT—epilepsy syndrome	2.51e-06	3.05e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.49e-06	3.03e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.49e-06	3.03e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.48e-06	3.03e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PRKCB—epilepsy syndrome	2.47e-06	3.01e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—SRC—epilepsy syndrome	2.47e-06	3.01e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—POMC—epilepsy syndrome	2.47e-06	3e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6ST—epilepsy syndrome	2.46e-06	3e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—APOE—epilepsy syndrome	2.46e-06	2.99e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—AKT1—epilepsy syndrome	2.45e-06	2.99e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—POMC—epilepsy syndrome	2.45e-06	2.98e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.43e-06	2.96e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.43e-06	2.95e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCL2—epilepsy syndrome	2.41e-06	2.94e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—VEGFA—epilepsy syndrome	2.41e-06	2.93e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	2.4e-06	2.93e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—POMC—epilepsy syndrome	2.4e-06	2.92e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCL2—epilepsy syndrome	2.4e-06	2.92e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.39e-06	2.91e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AGT—epilepsy syndrome	2.37e-06	2.89e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.37e-06	2.88e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.36e-06	2.87e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCL2—epilepsy syndrome	2.35e-06	2.86e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	2.34e-06	2.85e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SRC—epilepsy syndrome	2.33e-06	2.84e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—APOE—epilepsy syndrome	2.32e-06	2.83e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.32e-06	2.82e-05	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.31e-06	2.82e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.31e-06	2.81e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.3e-06	2.8e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	2.29e-06	2.79e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.27e-06	2.77e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—VEGFA—epilepsy syndrome	2.27e-06	2.77e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.27e-06	2.76e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—POMC—epilepsy syndrome	2.25e-06	2.74e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.25e-06	2.74e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.22e-06	2.71e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—TH—epilepsy syndrome	2.21e-06	2.7e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	2.21e-06	2.69e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.19e-06	2.67e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—FGF2—epilepsy syndrome	2.18e-06	2.66e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.18e-06	2.65e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.18e-06	2.65e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	2.17e-06	2.65e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	2.17e-06	2.64e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.17e-06	2.64e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—FGF2—epilepsy syndrome	2.17e-06	2.64e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.17e-06	2.64e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—TH—epilepsy syndrome	2.16e-06	2.63e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.16e-06	2.63e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.15e-06	2.61e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	2.13e-06	2.59e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	2.12e-06	2.58e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—POMC—epilepsy syndrome	2.11e-06	2.57e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.1e-06	2.55e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.1e-06	2.55e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	2.08e-06	2.54e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.07e-06	2.52e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.05e-06	2.49e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.04e-06	2.49e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—TH—epilepsy syndrome	2.04e-06	2.48e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.03e-06	2.47e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RELA—epilepsy syndrome	2.02e-06	2.47e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—TH—epilepsy syndrome	2.02e-06	2.46e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	2.01e-06	2.45e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	2.01e-06	2.44e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	2e-06	2.43e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—POMC—epilepsy syndrome	2e-06	2.43e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	1.99e-06	2.43e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.99e-06	2.42e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MTOR—epilepsy syndrome	1.99e-06	2.42e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	1.97e-06	2.4e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	1.97e-06	2.4e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	1.93e-06	2.35e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ALB—epilepsy syndrome	1.92e-06	2.34e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	1.85e-06	2.25e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.85e-06	2.25e-05	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AKT1—epilepsy syndrome	1.84e-06	2.24e-05	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	1.83e-06	2.23e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.83e-06	2.23e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CASP3—epilepsy syndrome	1.83e-06	2.22e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.82e-06	2.22e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ALB—epilepsy syndrome	1.82e-06	2.22e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	1.81e-06	2.21e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	1.81e-06	2.21e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.8e-06	2.2e-05	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.79e-06	2.18e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.79e-06	2.18e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CAT—epilepsy syndrome	1.78e-06	2.17e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	1.78e-06	2.16e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.77e-06	2.16e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—JUN—epilepsy syndrome	1.77e-06	2.16e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	1.76e-06	2.15e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	1.73e-06	2.1e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	1.73e-06	2.1e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	1.71e-06	2.09e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.71e-06	2.08e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.7e-06	2.07e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.69e-06	2.05e-05	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.68e-06	2.05e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—epilepsy syndrome	1.68e-06	2.05e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	1.68e-06	2.04e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.68e-06	2.04e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	1.67e-06	2.04e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	1.67e-06	2.03e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.67e-06	2.03e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.66e-06	2.02e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.66e-06	2.02e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.66e-06	2.02e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.65e-06	2.01e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.63e-06	1.99e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.63e-06	1.98e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	1.62e-06	1.97e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.62e-06	1.97e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.62e-06	1.97e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.61e-06	1.96e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	1.59e-06	1.94e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SRC—epilepsy syndrome	1.59e-06	1.94e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	1.58e-06	1.92e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	1.58e-06	1.92e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	1.55e-06	1.89e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	1.55e-06	1.88e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.54e-06	1.87e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AKT1—epilepsy syndrome	1.54e-06	1.87e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.53e-06	1.86e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.52e-06	1.85e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.51e-06	1.84e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.5e-06	1.83e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.5e-06	1.83e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.49e-06	1.82e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.47e-06	1.79e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	1.45e-06	1.77e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AKT1—epilepsy syndrome	1.45e-06	1.76e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.45e-06	1.76e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.42e-06	1.73e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.42e-06	1.73e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.42e-06	1.72e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.42e-06	1.72e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AGT—epilepsy syndrome	1.41e-06	1.72e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APOE—epilepsy syndrome	1.38e-06	1.68e-05	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.37e-06	1.66e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.35e-06	1.65e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.35e-06	1.65e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.34e-06	1.63e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—TH—epilepsy syndrome	1.33e-06	1.62e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.33e-06	1.62e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.32e-06	1.61e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.31e-06	1.6e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.3e-06	1.59e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.29e-06	1.57e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.28e-06	1.56e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.24e-06	1.51e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.22e-06	1.48e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—POMC—epilepsy syndrome	1.19e-06	1.45e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.18e-06	1.44e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.15e-06	1.4e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.12e-06	1.36e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.11e-06	1.35e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.11e-06	1.35e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.11e-06	1.35e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.1e-06	1.34e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ALB—epilepsy syndrome	1.08e-06	1.32e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.07e-06	1.3e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.02e-06	1.24e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.01e-06	1.23e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GPX1—epilepsy syndrome	9.92e-07	1.21e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	9.89e-07	1.2e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	9.82e-07	1.2e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	9.71e-07	1.18e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	9.62e-07	1.17e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—epilepsy syndrome	9.48e-07	1.15e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	9.04e-07	1.1e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	8.93e-07	1.09e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	8.85e-07	1.08e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.7e-07	1.06e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOE—epilepsy syndrome	8.52e-07	1.04e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AKT1—epilepsy syndrome	8.46e-07	1.03e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AKT1—epilepsy syndrome	8e-07	9.74e-06	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	7.33e-07	8.92e-06	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—POMC—epilepsy syndrome	7.32e-07	8.91e-06	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.67e-07	8.13e-06	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.84e-07	7.11e-06	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AKT1—epilepsy syndrome	4.88e-07	5.94e-06	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AKT1—epilepsy syndrome	4.76e-07	5.8e-06	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4.49e-07	5.46e-06	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.45e-07	5.42e-06	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.93e-07	3.57e-06	CbGpPWpGaD
